The logic of adjudication : an analysis of the grounds for judicial assertion by Levin, J

Conformational changes induced by salt in complexes of histones and superhelical nuclear DNA. by Levin, J, Cook, P

Reconstruction of complexes of histone and superhelical nuclear DNA. by Levin, J, Cook, P

The dissociation of nuclear proteins from superhelical DNA. by Levin, J, Jost, E, Cook, P

Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis by Piddlesden, S, Jiang, S, Levin, J, Vincent, A, Morgan, B

Clustering based on adherence data. by Kiwuwa-Muyingo, S, Oja, H, Walker, SA, Ilmonen, P, Levin, J, Todd, J

Universal immunization of infants with low doses of a low-cost, plasma-derived hepatitis B vaccine in South Africa by Schoub B.D., Matai U., Singh B., Blackburn N.K., Levin J.B.

Get full text

Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults... by Kiwuwa-Muyingo, S, Oja, H, Walker, A, Ilmonen, P, Levin, J, Mambule, Reid, A, Mugyenyi, P, Todd, J

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe. by Kiwuwa-Muyingo, S, Walker, A, Oja, H, Levin, J, Miiro, G, Katabira, E, Kityo, C, Hakim, J, Todd, J

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe. by Muyingo, S, Walker, A, Reid, A, Munderi, P, Gibb, D, Ssali, F, Levin, J, Katabira, E, Gilks, C, Todd, J

P04-11. Prevalence of neutralizing antibody responses in chronic clades A and D human immunodeficiency virus type 1 (HIV-1) infections by Grosskurth H, Kamali A, Maher D, Levin J, Vanham G, Balla S, Montefiori D, Sokolik-Wolak B, Tomusange K, Njai HF, Pala P, Kaleebu P

The effect of current Schistosoma mansoni infection on the immunogenicity of a candidate TB vaccine, MVA85A, in BCG-vaccinated adolescents: An open-label trial by Wajja, A, Kizito, D, Nassanga, B, Nalwoga, A, Kabagenyi, J, Kimuda, S, Galiwango, R, Mutonyi, G, Vermaak, S, Satti, I, Verweij, J, Tukahebwa, E, Cose, S, Levin, J, Kaleebu, P, Elliott, A, McShane, H

Lessons from the first clinical trial of a non-licensed vaccine among Ugandan adolescents: a phase II field trial of the tuberculosis candidate vaccine, MVA85A by Wajja, A, Namutebi, M, Apule, B, Oduru, G, Kiwanuka, S, Akello, M, Nassanga, B, Kabagenyi, J, Mpiima, J, Vermaak, S, Lawrie, A, Satti, I, Verweij, J, Cose, S, Levin, J, Kaleebu, P, Tukahebwa, E, McShane, H, Elliott, A

Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-c... by Zhang, Y, Xu, J, Levin, J, Hegen, M, Li, G, Robertshaw, H, Brennan, F, Cummons, T, Clarke, D, Vansell, N, Nickerson-Nutter, C, Barone, D, Mohler, K, Black, R, Skotnicki, J, Gibbons, J, Feldmann, M, Frost, P, Larsen, G, Lin, L

Eighth International Chorea–Acanthocytosis Symposium: summary of workshop discussion and action Points by Pappas, S, Bonifacino, J, Danek, A, Dauer, W, De, M, De Franceschi, L, Dipaolo, G, Fuller, R, Haucke, V, Hermann, A, Kornmann, B, Landwehrmeyer, B, Levin, J, Neiman, A, Rudnicki, D, Sibon, O, Velayos Baeza, A, Vonk, J, Walker, R, Weisman, L, Albin, R